REFINE Study Evaluating Aurora Spine ZIP MIS Interspinous Fusion System
for Chronic Low Back Pain with Degenerative Disc Disease and Neurogenic Claudication
Led by Pacific Research Institute · Updated on 2022-08-18
100
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of the Aurora Spine ZIP MIS Interspinous Fusion System combined with bone graft material in adults with chronic low back pain caused by degenerative disc disease and neurogenic claudication. This condition involves deterioration in the spine that can cause pain and difficulty walking. The study aims to provide insight into this device as a treatment option compared to existing therapies.
The study uses the Aurora Spine ZIP device, a bilateral locking plate system that attaches to the spinous processes in the lower spine from T1 to S1 through a minimally invasive interlaminar approach. The device includes articulations and a central chamber for bone graft material to support fusion at a single spinal level. Participants have already tried at least three months of non-operative treatments before receiving this implant.
During the study, participants will be monitored for improvements in pain and function at 3 and 12 months after the procedure. Researchers will collect data on pain relief using the Visual Analog Scale VAS, physical function scores, patient global impression of change, imaging outcomes, and complication rates. The study involves multiple centers and follows participants over time to assess real-world effectiveness and safety of this fusion device.
CONDITIONS
Brief Title
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Research Team
S
Shelley Trimm, BS
K
Kam Murrell
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Investigational device (REFINE study)
Usual surgical care outside trial
What it is
A minimally invasive interspinous fusion device attaching to the spinous processes plus bone graft, evaluated in a single‑arm multi‑centre study
Decompressive surgery, often with spinal fusion, is the standard surgical approach for similar lumbar spinal stenosis patients
Role in trial
All participants receive the investigational device as a single treatment arm
Not studied within this trial, provided here only for external comparison context
Primary use
To stabilize degenerative lumbar levels and reduce neurogenic claudication in patients with degenerative disc disease
To relieve nerve compression by surgical decompression and, if needed, stabilise the spine via fusion
How it's performed
Implanted via minimally invasive interlaminar approach attaching to spinous processes plus bone graft
Performed as a decompressive laminectomy with or without instrumented fusion through open surgery
Evidence status
Early single‑arm data assessing safety and pain/function improvement at 3 and 12 months
Decompression (with or without fusion) has established evidence supporting early symptom relief and functional recovery
Important risks
Risks not yet fully characterized; safety assessed as part of trial follow‑up
Open decompression and fusion carry known surgical risks including blood loss, infection, longer recovery
Open surgery is more invasive with potential for greater morbidity and longer hospital stay
Patient impact
Potential for symptom relief and functional improvement under evaluation
Typically provides symptom relief and functional recovery demonstrated in surgical series
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Provide written informed consent before any study procedure
Be 18 years or older and skeletally mature
Have 1-2 symptomatic lumbar degenerative disc disease levels (T12-S1), with or without grade I spondylolisthesis confirmed by history and imaging
Have MRI within 12 months showing at least mild to moderate spinal stenosis at the treatment level
Have undergone at least 3 months of non-operative treatment
Present with Zurich Claudication Questionnaire (ZCQ) physical function score of 2.0 or higher at baseline
Report relief from lumbar flexion and/or sitting
Have baseline Visual Analog Scale (VAS) back and/or leg pain while standing or walking of 50 mm or more
You will not qualify if you...
Unable to provide written informed consent
Previous lumbar spine surgery at the intended treatment level
Grade II or greater spondylolisthesis with 3mm or more instability on flexion and extension X-rays
Confirmed or suspected osteoporosis or osteopenia
Participation in another investigational drug or device study that could affect trial results
Other medical, social, or psychological conditions that would limit participation or compliance
Pregnancy or nursing
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Single surgical procedure with immediate recovery period
Participants undergo implantation of the Aurora Spine ZIP™ MIS Interspinous Fusion device for treatment of lumbar degenerative disc disease with neurogenic claudication.
1 visit (surgery and immediate care)
Post-operative Follow-up
Duration - 12 months
Participants are monitored for safety and effectiveness of the implanted device, including assessments of pain and function.
Visits at approximately 3 and 12 months after implantation
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Activity Changes in Elderly Patients With Lumbar Spinal Stenosis Before and After Decompressive Surgery
Study to Identify Transthyretin Cardiac Amyloidosis in Adults Over 50 With Previous Lumbar Spine Surgery
Using Spinal Tissue Analysis and Heart Imaging
Study of Balance Changes in Elderly Patients With Lumbar Spinal Stenosis Undergoing Decompressive Surgery
Prevalence of Peripheral Artery Disease in Adults with Lumbar Spinal Stenosis Undergoing Surgery
Comparing L-Unitary Soft Endoscope LUSE and Minimally Invasive Transforaminal Lumbar Interbody Fusion MIS-TLIF for Single-Level Lumbar Spinal Stenosis in Adults Aged 40 to 70
Comparing Endo-Surgi Plus, UBE Endoscopy, and Microdiscectomy for Treating Lumbar Spinal Stenosis
A Multicenter Study on Effectiveness and Safety of Minimally Invasive Spine Surgeries
Comparing Two Surgical Methods for Treating Multilevel Lumbar Spinal Stenosis Decompressive Laminectomy Alone Versus Laminectomy With Transpedicular Screw Fixation
Studying How Degenerative Spondylolisthesis Affects Outcomes After Unilateral Biportal Endoscopy Surgery for Lumbar Spinal Stenosis in Adults Aged 50 to 80
Impact of Fluid Bag Height and Incision Direction on Irrigation Pressure and Surgical Clarity in Unilateral Biportal Endoscopic Spine Surgery
Evaluating Modified Release Metaxalone 640 mg for Acute Lumbar Spinal Stenosis and Sciatica Pain Relief
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A Prospective, Observational, Open-Label, Non-Randomized, Multicenter Study Measuring Functional Outcomes in a Novel Interspinous Fusion Device in Subjects with Low Back Pain: REFINE Study.